Experiment 68958

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationZHAO,QY: IYER,GR: VERHAEGHE,T: TRUYEN,L:. (2002). PHARMACOKINETICS AND SAFETY OF GALANTAMINE IN SUBJECTS WITH HEPATIC IMPAIRMENT AND HEALTHY VOLUNTEERS.. 42(4)
Amount utilized
Compound isolated
DiseaseTHE PHARMACOKINETICS OF GALANTHAMINE IN SUBJECTS WITH MILD HEPATIC IMPAIRMENT WAS SIMILAR TO THOSE IN HEALTHY SUBJECTS. IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT, GALANTHAMINE WITH NORMAL VOLUNTEERS. GALANTHAMINE WAS ALSO WELL TOLERATED AND APPEARED TO BE SAFE IN SUBJECTS WITH MILD OR MODERATE HEPATIC IMPAIRMENT.
Dose amount4.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES